Cite
HARVARD Citation
Palaparthy, R. et al. (2018). A randomized study comparing the pharmacokinetics of the potential biosimilar PF-06438179/GP1111 with Remicade® (infliximab) in healthy subjects (REFLECTIONS B537-01). Expert review of clinical immunology. pp. 329-336. [Online].